WS #10446
Definium Therapeutics shares rally up to 60% on groundbreaking late-stage trial results for major depressive disorder treatment.
Definium Therapeutics Positive Trial Data
Definium Therapeutics shares rally up to 60% on groundbreaking late-stage trial results for major depressive disorder treatment.